In Brief This Week: Sigma-Aldrich; Bruker, Vutara; Qiagen; Xifin; Enzo Biochem; Accelerator; Bio-Techne, ProteinSimple | GenomeWeb

NEW YORK (GenomeWeb) – Sigma-Aldrich said in its Form 10-Q filed last week with the US Securities and Exchange Commission that it expects to eliminate about 80 jobs resulting from an upcoming facility consolidation in Europe. Employee termination costs are anticipated to be around $4 million, while potential asset disposal costs are estimated at up to $12 million. The company said that it expects closure activities to begin in the second half of 2014. Sigma-Aldrich had about 9,000 employees as of Dec. 31, 2013.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.